SMTL ID : 6qfc.1

Structure of an anti-Mcl1 scFv

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.96 Å

Oligo State

hetero-1-1-mer

Ligands

5 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.1: 6 residues within 4Å: Chain A: W.96, Q.144, F.153 Chain B: A.102, W.104 Ligands: DMS.5 2 PLIP interactions: 1 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:Q.144 pi-Cation interactions: B:W.104 DMS.2: 7 residues within 4Å: Chain B: K.43, G.44, D.221, Y.223, G.238, G.239, K.241 1 PLIP interactions: 1 interactions with chain B Salt bridges: B:D.221 DMS.3: 4 residues within 4Å: Chain B: V.93, Q.111, G.112, L.114 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:L.114 DMS.4: 2 residues within 4Å: Chain B: Q.1, V.2 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:V.2 DMS.5: 7 residues within 4Å: Chain A: K.143 Chain B: T.103, W.104, N.167, T.168, W.227 Ligands: DMS.1 1 PLIP interactions: 1 interactions with chain B Water bridges: B:T.168

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Luptak, J. et al., Antibody fragments structurally enable a drug-discovery campaign on the cancer target Mcl-1. Acta Crystallogr D Struct Biol (2019)

Release Date

2019-11-06

Peptides

Induced myeloid leukemia cell differentiation protein Mcl-1: A
scFv55: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Induced myeloid leukemia cell differentiation protein Mcl-1

scFv55

Related Entries With Identical Sequence